Targeted Clinical Development |
Jane Lebkowski |
Evaluation of Safety and Preliminary Efficacy of Escalating Doses of GRNOPC1 in Subacute Spinal Cord Injury |
$0 |
Disease Team Therapy Planning I |
Jane Lebkowski |
Preclinical Development and First-In-Human Testing of GRNCM1 in Advanced Heart Failure |
$0 |